An initial public offering of more than 17.2 million shares on the Swedish stock exchange, Nasdaq Stockholm, has brought in $57.4 million for Sweden-based Bonesupport. The company will use the proceeds to support sales expansion for its drug-eluting bone scaffolds that use the Cerament technology platform.
Swedish IPO pulls in $57.4M for Bonesupport
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.